Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Andrology ; 3(3): 506-11, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25873521

RESUMO

Hepatitis B virus (HBV) in semen is important for father-to-child transmission of HBV and has adverse effects on sperm quality. However, risk factors associated with HBV in semen remain unclear. Serum HBV DNA and hepatitis B e antigen (HBeAg) levels may pose a risk on HBV in semen. This study aims to examine whether serum HBV DNA, HBeAg, and hepatitis B surface antigen (HBsAg) level were associated with HBV DNA in semen. 151 male patients chronically infected with HBV from infertile couples were included. Serum HBsAg and HBeAg were determined using an electrochemiluminescence immune assay (ECLIA). Serum and seminal plasma HBV DNA were detected by the QIAGEN Real-Time HBV DNA assay. Of 151 patients, 143 (94.7%) were serum HBV DNA-positive and 65 (43.0%) were seminal plasma HBV DNA-positive. Serum HBV DNA and HBeAg level of seminal plasma HBV DNA-positive patients were significantly higher (p < 0.001) as compared with those of seminal plasma HBV DNA-negative patients, HBsAg level of seminal plasma HBV DNA-positive patients was significantly lower (p < 0.001) compared with that of seminal plasma HBV DNA-negative patients. The best serum HBV DNA, HBeAg, and HBsAg value for discriminating between seminal plasma HBV DNA-positive and HBV DNA-negative patients were ≥6.9 log10 IU/mL (sensitivity 100.0%, specificity 90.7%), >14.8 S/CO (sensitivity 96.9%, specificity 81.5%), and <1791.5 S/CO (sensitivity 81.5%, specificity 81.2%), respectively. The combination of serum HBV DNA and HBeAg had high diagnostic sensitivity (100.0%) and specificity (95.4%) for the presence of HBV DNA in semen. As such, these serum markers especially the combination of HBV DNA and HBeAg are useful predictors of the presence of HBV DNA in semen in HBV chronically infected men from infertile couples.


Assuntos
DNA Viral/sangue , Antígenos de Superfície da Hepatite B/sangue , Antígenos E da Hepatite B/sangue , Vírus da Hepatite B/genética , Sêmen/virologia , Adulto , Biomarcadores/sangue , DNA Viral/genética , Hepatite B Crônica/genética , Hepatite B Crônica/transmissão , Hepatite B Crônica/virologia , Humanos , Medições Luminescentes , Masculino , Pessoa de Meia-Idade , Análise do Sêmen , Espermatozoides/virologia , Adulto Jovem
2.
Biosci Biotechnol Biochem ; 61(3): 514-9, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9095554

RESUMO

Atherosclerotic lesions of the thoracic aorta were induced in exogenously hypercholesterolemic (ExHC) rats by treating initially with hypervitamin D2 and subsequently feeding on hypercholesterolemic diets for 180 days. Dietary soybean protein, in comparison with casein, substantially decreased the degree of atherosclerotic lesions, which was evaluated by intimal thickening, although with a similar topographical distribution. The casein-fed rats tended to maintain a high concentration of serum cholesterol, particularly in triacylglycerol-rich lipoproteins. The concentrations of apo A-I and TBARS in the serum was comparable between the dietary protein groups. The data suggest that dietary soybean protein, compared to casein, produced lipoproteins which were less atherosclerotic by partitioning cholesterol in the triacylglycerol-poor lipoproteins.


Assuntos
Aorta Torácica/efeitos dos fármacos , Arteriosclerose/prevenção & controle , Caseínas/farmacologia , Hipercolesterolemia/tratamento farmacológico , Proteínas de Soja/farmacologia , Animais , Aorta Torácica/lesões , Aorta Torácica/patologia , Apolipoproteína A-I/sangue , Arteriosclerose/tratamento farmacológico , Arteriosclerose/fisiopatologia , Caseínas/administração & dosagem , Colesterol/sangue , Modelos Animais de Doenças , Ergocalciferóis/administração & dosagem , Ergocalciferóis/toxicidade , Hipercolesterolemia/induzido quimicamente , Masculino , Ratos , Proteínas de Soja/administração & dosagem , Proteínas de Soja/uso terapêutico , Coloração e Rotulagem , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Triglicerídeos/sangue
3.
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...